Hannover Dialysis Outcome Study

PHASE4CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

May 31, 2006

Conditions
Acute Kidney Failure
Interventions
DEVICE

Standard extended dialysis

Standard extended dialysis dosed to maintain plasma urea levels between 120-150 mg/dL (20 -25 mmol/L)

DEVICE

Intensified extended dialysis

Intensified extended dialysis dosed to maintain near-normal plasma urea levels, i.e. \<90 mg/dL (\<15 mmol/L)

Trial Locations (1)

30625

Hannover Medical School, Hanover

All Listed Sponsors
collaborator

Fresenius AG

INDUSTRY

lead

Hannover Medical School

OTHER

NCT00529139 - Hannover Dialysis Outcome Study | Biotech Hunter | Biotech Hunter